Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Family Medicine

Clinical Pharmacology

Long-term risk of skin cancer and lymphoma in users of topical tacrolimus and pimecrolimus: Final results from the extension of the cohort study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

Clinical Epidemiology | Jan 06, 2022 Clinical Pharmacology

Trial of spesolimab for generalized pustular psoriasis

New England Journal of Medicine | Jan 05, 2022 Clinical Pharmacology

Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: Placebo-controlled, randomized, phase III clinical trial (ECZTRA 7)

British Journal of Dermatology | Jan 05, 2022 Clinical Pharmacology

Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials

Metabolism | Jan 05, 2022 Clinical Pharmacology

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus

BMC Gastroenterology | Jan 05, 2022 Clinical Pharmacology

Hydroxychloroquine use and cardiovascular events among patients with systemic lupus erythematosus and rheumatoid arthritis

Arthritis Care & Research | Jan 05, 2022 Clinical Pharmacology

Bleeding risk of dual antiplatelet therapy after minor stroke or TIA

Annals of Neurology | Jan 05, 2022 Clinical Pharmacology

Rivaroxaban vs apixaban and major ischemic or hemorrhagic events in patients with atrial fibrillation

JAMA | Dec 26, 2021 Clinical Pharmacology

Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: Results from two phase III, long-term studies

British Journal of Dermatology | Dec 26, 2021 Clinical Pharmacology

Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS)

Clinical Endocrinology | Dec 26, 2021 Clinical Pharmacology

« Prev 1 … 9 10 11 12 13 … 393 Next »

Long-term risk of skin cancer and lymphoma in users of topical tacrolimus and pimecrolimus: Final results from the extension of the cohort study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

Trial of spesolimab for generalized pustular psoriasis

Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: Placebo-controlled, randomized, phase III clinical trial (ECZTRA 7)

Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus

Hydroxychloroquine use and cardiovascular events among patients with systemic lupus erythematosus and rheumatoid arthritis

Bleeding risk of dual antiplatelet therapy after minor stroke or TIA

Rivaroxaban vs apixaban and major ischemic or hemorrhagic events in patients with atrial fibrillation

Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: Results from two phase III, long-term studies

Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS)

Article: 2025 Latest Guidelines for Managing Acute Coronary Syndromes

Pre-Vodcast Quiz: Test Your Knowledge on the Impact of Stress and Gut Health

Article: Depression and Anxiety Screening in Primary Care

Researchers may have solved decades-old mystery behind benzodiazepine side effects

Hyperbaric oxygen treatment provide long-term relief for radiation-induced injuries

Long-term risk of skin cancer and lymphoma in users of topical tacrolimus and pimecrolimus: Final results from the extension of the cohort study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

Trial of spesolimab for generalized pustular psoriasis

Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: Placebo-controlled, randomized, phase III clinical trial (ECZTRA 7)

Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus

Hydroxychloroquine use and cardiovascular events among patients with systemic lupus erythematosus and rheumatoid arthritis

Bleeding risk of dual antiplatelet therapy after minor stroke or TIA

Rivaroxaban vs apixaban and major ischemic or hemorrhagic events in patients with atrial fibrillation

Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: Results from two phase III, long-term studies

Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS)

Article: 2025 Latest Guidelines for Managing Acute Coronary Syndromes

Pre-Vodcast Quiz: Test Your Knowledge on the Impact of Stress and Gut Health

Article: Depression and Anxiety Screening in Primary Care

Researchers may have solved decades-old mystery behind benzodiazepine side effects

Hyperbaric oxygen treatment provide long-term relief for radiation-induced injuries

Select Specialty

Select Topic